IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ANTONARELLI, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.429
AS - Asia 915
NA - Nord America 525
SA - Sud America 93
AF - Africa 17
OC - Oceania 11
Totale 2.990
Salva come PNG Salva come JPEG
Nazione #
DE - Germania 1.074
US - Stati Uniti d'America 502
SG - Singapore 332
CN - Cina 321
SE - Svezia 90
HK - Hong Kong 82
IT - Italia 81
IN - India 72
BR - Brasile 71
RU - Federazione Russa 48
FR - Francia 38
NL - Olanda 29
ID - Indonesia 26
VN - Vietnam 23
IE - Irlanda 17
GB - Regno Unito 14
FI - Finlandia 12
JP - Giappone 10
CA - Canada 9
PL - Polonia 9
TR - Turchia 9
KR - Corea 8
MX - Messico 8
AR - Argentina 7
AT - Austria 7
AU - Australia 7
CI - Costa d'Avorio 7
TW - Taiwan 5
ZA - Sudafrica 5
BD - Bangladesh 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
SA - Arabia Saudita 4
BE - Belgio 3
CO - Colombia 3
EC - Ecuador 3
JM - Giamaica 3
PH - Filippine 3
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
IQ - Iraq 2
KG - Kirghizistan 2
PE - Perù 2
TN - Tunisia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
ET - Etiopia 1
HU - Ungheria 1
JO - Giordania 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PY - Paraguay 1
RO - Romania 1
UA - Ucraina 1
Totale 2.990
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.040
Singapore 147
Ashburn 123
Hong Kong 75
Hefei 61
Santa Clara 53
Beijing 52
Los Angeles 41
Dallas 35
Bengaluru 31
Milan 25
Boardman 21
Chandler 20
Hyderabad 18
Council Bluffs 17
Dublin 17
Jakarta 16
Shanghai 14
New York 13
Cangzhou 11
Munich 11
Hanoi 10
Moscow 10
Guangzhou 9
Boston 8
Chennai 8
Istanbul 8
Abidjan 7
Buffalo 7
Ho Chi Minh City 7
Oklahoma City 7
Tokyo 7
Nuremberg 6
Quanzhou 6
Rho 6
São Paulo 6
Düsseldorf 5
Helsinki 5
Lauterbourg 5
Paris 5
Seattle 5
Warsaw 5
Wuhan 5
Bari 4
Huizhou 4
Lappeenranta 4
Montreal 4
Ranchi 4
Roubaix 4
Seoul 4
Sydney 4
Vienna 4
Belmont 3
Brasília 3
Charlotte 3
Chicago 3
Fuzhou 3
Islamabad 3
Nanjing 3
Naples 3
Portsmouth 3
Princeton 3
Redmond 3
Reggio Emilia 3
Rio de Janeiro 3
San Diego 3
San Jose 3
Taipei 3
Turku 3
Wroclaw 3
Atlanta 2
Baghdad 2
Barranquilla 2
Bishkek 2
Bollate 2
Brisbane 2
Brooklyn 2
Brussels 2
Bühl 2
Cairo 2
Cambridge 2
Chingford 2
Cleveland 2
Dammam 2
Denver 2
Dhaka 2
Fairfield 2
Florence 2
Fortaleza 2
Gainesville 2
Groningen 2
Guayaquil 2
Haiphong 2
Hangzhou 2
Johannesburg 2
Kent 2
Kingston 2
La Paz 2
Lima region 2
Manila 2
Totale 2.138
Salva come PNG Salva come JPEG
Nome #
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure 226
Systemic Treatment of Ductal Carcinoma In Situ of the Breast 190
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 188
The Immune-related adverse event (IRAE) Likelihood Score (ILS) identifies “pure” IRAEs strongly associated with outcome in a phase I-II trial population 161
Safety of covid-19 mrna vaccines in patients with cancer enrolled in early-phase clinical trials 159
Continuous sunitinib schedule in advanced platinum refractory thymic epithelial neoplasms: A retrospective analysis from the ThYmic MalignanciEs (TYME) Italian collaborative group 155
The rare entity of gastrointestinal leiomyosarcomas: An Italian multicenter retrospective study in high‐volume referral centers 142
Research and clinical landscape of bispecific antibodies for the treatment of solid malignancies 142
Immune-related adverse events are correlated with significantly improved outcome in a phase I trial population exposed to combination immunotherapy 138
COVID-19 related risk in patients enrolled in early-phase clinical trials 133
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population 130
Therapeutic Cancer Vaccines Revamping: Technology Advancements and Pitfalls 129
Targeting brain metastases in breast cancer 127
Seroconversion rate after vaccination against COVID-19 in patients with cancer—a systematic review 124
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 122
Cyclin dependent kinase 4/6 inhibitors in early breast cancer: what is the role of Ki-67? 122
Harmonizing PD-L1 testing in metastatic triple negative breast cancer 122
Histology-agnostic approvals for antibody-drug conjugates in solid tumours: is the time ripe? 115
Investigational immunomodulatory drugs for enhancement of triple negative breast cancer (TNBC) immunotherapy: early phase development 111
An update on promising and emerging protein kinase B/AKT inhibitors for breast cancer 95
Targeting Post-Translational Modifications to Improve Combinatorial Therapies in Breast Cancer: The Role of Fucosylation 66
Immune-Related Adverse Event Likelihood Score Identifies “Pure” IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population 62
Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study 49
The CDK4/6 inhibitors biomarker landscape: The most relevant biomarkers of response or resistance for further research and potential clinical utility 42
Pembrolizumab and oral metronomic cyclophosphamide in patients with chest wall breast cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1) 3
Totale 3.053
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.195
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 1 4 9 4 9 12 5 3 2 2
2022/2023118 8 12 21 10 12 23 7 1 6 3 9 6
2023/20241.000 16 17 29 34 72 54 163 126 61 127 151 150
2024/20251.020 122 137 130 112 58 27 17 59 45 80 76 157
2025/2026864 213 175 168 159 112 37 0 0 0 0 0 0
Totale 3.053